DIA Europe 2019 has ended
Back To Schedule
Thursday, February 7 • 10:45 - 11:45
#S0206: Regulatory Innovation: Regulatory Science

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

We will discuss the current vibrant environment on science and technology innovation from in academia, industry and society as well as the challenges posed to regulators to enable fast development and access to the innovative medicine(s) solutions.


Beatriz Silva Lima, PharmD, PhD


Regulatory Science in the Next Decade
Beatriz Silva Lima, PharmD, PhD

Multistakeholders’ Interaction is a Key Success Factor for any IMI project – the Experience of the IMI PROactive in COPD Consortium
Solange Corriol-Rohou, DrMed, MD, PhD

Experimental Regulatory Research on Vaccines and CAR T Cells
Klaus Cichutek, PhD

The New Health Paradigm in a Smart World Environment
Marek Tyl, DrSc, MSc

Miguel Forte, FACP

avatar for Klaus Cichutek

Klaus Cichutek

President, Paul-Ehrlich-Institut
Prof. Dr. Klaus CICHUTEK is the President of the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, in Germany. PEI is a senior federal agency reporting to the German Federal Ministry of Health and member of the network of the European regulatory authorities united... Read More →
avatar for Solange Corriol-Rohou

Solange Corriol-Rohou

Senior Director, Global Regulatory Affairs & Policy, R&D, Europe, AstraZeneca
Pulmonologist and immuno-allergist by training, Solange joined AstraZeneca R&D in 2004 and is currently Sr. Global Policy Director, with responsibilities in the Respiratory/Infection and Vaccine/Immune therapies franchise. Over the past 20 years, moving from the French Medicines Agency/EMA... Read More →

Miguel Forte

Chief Executive Officer, Miguel Forte
avatar for Beatriz Silva Lima

Beatriz Silva Lima

Professor of Pharmacology; NDA Advisory Board, NDA Advisory Services Limited
i) Coordinates the Group of Pharmacological Sciences of the iMed.ULisboa, ii) for 20 years acted as expert in nonclinical and regulatory science at Infarmed, Portugal and EMEA, UK iii) has been (end July 2012) member of CHMP, CAT and SAWP and Chair of Safety Working Party and EU Co-Deputy... Read More →

Marek Tyl

CEO, Innovation Forum
Marek is a scientist, manager and a technology commercialisation strategist. He completed his PhD at the Department of Biochemistry, University of Cambridge followed by a Post Doc at Imperial College London (chromatin biology). Marek is the Founder and CEO of the Innovation Forum... Read More →

Thursday February 7, 2019 10:45 - 11:45 CET
G1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  02 Evolution of Science and Policy, Session
  • Featured Topics Translational Medicine
  • Tags Session